Pharmacovigilance and Regulatory Affairs

Automation in Case Processing and Reporting

Automation is revolutionizing pharmacovigilance case processing by streamlining repetitive tasks and accelerating the management of large volumes of safety data. Tools such as robotic process automation (RPA), natural language processing (NLP), and machine learning algorithms are reducing manual workload, increasing efficiency, and minimizing human error. These technologies enable faster data intake, triage, coding, narrative generation, and regulatory submission of individual case safety reports (ICSRs). By automating routine processes, safety professionals can focus on complex tasks like medical evaluation, signal detection, and benefit-risk analysis. Additionally, automation supports real-time compliance tracking and audit readiness, critical for meeting global regulatory timelines.

Despite its advantages, implementing automation requires careful validation, robust quality control, and alignment with pharmacovigilance regulations such as GVP and 21 CFR Part 11. It also necessitates change management and skill development among safety teams. When strategically adopted, automation not only enhances operational scalability but also strengthens the overall pharmacovigilance ecosystem.